BioSpace News Archive

BioMidwest

Myriad Applauds New Consensus Statement From International Expert Panel On Screening Recommendations for Hereditary Prostate Cancer

The consensus recommendations point to the need for routine obtainment of family history information and hereditary cancer counselling for men with prostate cancer seen by either a urologist or oncologist.

January 22, 2018
·
6 min read
ProMIS Neurosciences Issues Response to Recent Market Activity

At the request of IIROC, ProMis Neurosciences wishes to confirm that it is not aware of any material, undisclosed information related to the Company that would account for the recent increase in the market price and level of trading volume of its ordinary shares.

January 22, 2018
·
2 min read
New Study Investigates the Clinical Utility of ORi™, Masimo Oxygen Reserve Index™, in Obese Patients

The researchers concluded that the study “demonstrates the ability of ORi to provide advanced warning of arterial desaturation as an adjunct to SpO2 in this high risk patient population.

January 22, 2018
·
7 min read
Drug Development

Astellas, Vical’s Lead CMV Vaccine Flunks Key Phase III Study

The drug did not meet its primary or secondary endpoints in the Phase 3 HELIOS clinical trial.

January 22, 2018
·
5 min read
Octapharma: Low Inhibitor Rate With Octanate® In Previously Untreated Patients (Pups) With Severe Haemophilia A

The study assessed the immunogenicity, efficacy, safety and tolerability of octanate® in PUPs with severe haemophilia A.

January 22, 2018
·
4 min read
Genetown

Agenus Closes $230M Royalty Monetization With HealthCare Royalty Partners

The transaction is comprised of approximately $190M of cash proceeds at closing plus up to approximately $40M in milestone payments.

January 22, 2018
·
2 min read
FDA

European Commission Approves Bristol-Myers Squibb’s Yervoy (ipilimumab) for Treatment of Pediatric Patients 12 Years and Older with Unresectable or Metastatic Melanoma

The EC approval marks Bristol-Myers Squibb’s first pediatric indication for an Immuno-Oncology medicine in the European Union (EU) and allows for the marketing of Yervoy for this indication in all 28 Member States of the EU.

January 22, 2018
·
19 min read
Business

Neovasc Names Former BeneChill CEO as New Leader

Neovasc’s outgoing CEO, will maintain his role as a Director on the Neovasc Board of Directors and continue to serve as an advisor to the Company.

January 22, 2018
·
10 min read
Biotech Beach

AVACEN Medical Device for Autistic Spectrum Disorder Behavior Management Launched in Hong Kong

Avacen Medical announced that it is launching sales of its AVACEN 100 in Hong Kong to address the challenge of autistic spectrum disorder behavior management.

January 22, 2018
·
4 min read
Business

Halozyme to Host Fourth Quarter and Full-Year 2017 Financial Results Conference Call

Dr. Helen Torley, president and chief executive officer, will lead the call.

January 22, 2018
·
2 min read